Cardiac MR PET CT Program, Division of Cardiology, and Department of Radiology, Massachusetts General Hospital, Boston, MA.
Circ Cardiovasc Imaging. 2013 Sep;6(5):747-54. doi: 10.1161/CIRCIMAGING.113.000382. Epub 2013 Jul 5.
Arterial calcium (Ca) deposition has been identified as an active inflammatory process. We sought to test the hypothesis that local vascular inflammation predisposes to subsequent arterial calcium deposition in humans.
From a hospital database, we identified 137 patients (age, 61 ± 13 years; 48.1% men) who underwent serial positron-emission tomography/computed tomography (1-5 years apart). Focal arterial inflammation was prospectively determined by measuring 18F-flourodeoxyglucose uptake (using baseline positron-emission tomography) within predetermined locations of the thoracic aortic wall and was reported as a standardized uptake value. A separate, blinded investigator evaluated calcium deposition (on the baseline and follow-up computed tomographic scans) along the same standardized sections of the aorta. New calcification was prospectively defined using square root-transformed difference of calcium volume score, with a cutoff value of 2.5. Accordingly, vascular segment was classified as either with or without subsequent calcification. Overall, 67 (9%) of aortic segments demonstrated subsequent calcification. Baseline median (interquartile range) standardized uptake value was higher in segments with versus without subsequent calcification (2.09 [1.84-2.44] versus 1.92 [1.72-2.20], P=0.002). This was also true in the subset of segments with Ca present at baseline (2.08 [1.81-2.40] versus 1.86 [1.66-2.09], P=0.02), as well as those without (2.17 [1.87-2.51] versus 1.93 [1.73-2.20], P=0.04). Furthermore, across all patients, subsequent Ca deposition was associated with the underlying 18F-flourodeoxyglucose uptake (inflammatory signal), measured as standardized uptake value (odds ratio [95% confidence interval]=2.94 [1.27-6.89], P=0.01) or target-to-background ratio (2.59 [1.18-5.70], =0.02), after adjusting for traditional cardiovascular risk factors.
Here, we provide first-in-man evidence that arterial inflammation precedes subsequent Ca deposition, a marker of plaque progression, within the underlying location in the artery wall.
动脉钙沉积已被确定为一种活跃的炎症过程。我们试图验证这样一个假设,即局部血管炎症易导致随后在人体动脉中钙沉积。
我们从医院的数据库中确定了 137 名患者(年龄 61±13 岁;48.1%为男性),他们接受了连续的正电子发射断层扫描/计算机断层扫描(间隔 1-5 年)。通过测量胸主动脉壁预定部位的 18F-氟脱氧葡萄糖摄取(使用基线正电子发射断层扫描),前瞻性地确定局部动脉炎症,并以标准化摄取值报告。一位单独的、盲法的研究者评估了主动脉同一标准化部位的钙沉积(在基线和随访计算机断层扫描上)。使用钙体积评分平方根差值来前瞻性地定义新的钙化,截断值为 2.5。因此,血管节段被分为有或无后续钙化。总的来说,67(9%)个主动脉节段出现了后续钙化。与无后续钙化的节段相比,有后续钙化的节段基线中位数(四分位间距)标准化摄取值更高(2.09[1.84-2.44]与 1.92[1.72-2.20],P=0.002)。在基线时存在钙的节段亚组中也是如此(2.08[1.81-2.40]与 1.86[1.66-2.09],P=0.02),以及在无钙的节段中也是如此(2.17[1.87-2.51]与 1.93[1.73-2.20],P=0.04)。此外,在所有患者中,随后的钙沉积与基础的 18F-氟脱氧葡萄糖摄取(炎症信号)相关,用标准化摄取值(比值比[95%置信区间]=2.94[1.27-6.89],P=0.01)或靶/背景比(2.59[1.18-5.70],P=0.02)表示,在调整了传统心血管危险因素后。
在这里,我们提供了首例人体证据,表明动脉炎症先于动脉壁下潜在部位随后的钙沉积,后者是斑块进展的标志物。